Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients

This multicenter prospective clinical study focuses on elderly patients with lung cancer. The investigators will build a standardized clinical registry database, develop perioperative risk stratification and surgical early-warning models, optimize individualized surgical regimens, construct multidisciplinary perioperative comprehensive therapy, integrated Chinese-Western medicine full-cycle management and personalized postoperative rehabilitation systems, so as to form a whole-process optimized treatment model for elderly lung cancer.

Trial Details

NCT ID
NCT07632664
Phase
NA
Sponsor
Peking University People's Hospital
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Pulmonary Lobectomy plus Mediastinal Lymph Node Sampling
  • Pulmonary Segmentectomy plus Mediastinal Lymph Node Sampling
  • Pulmonary Wedge Resection plus Mediastinal Lymph Node Sampling
Locations (sample)
  • Beijing, Beijing Municipality, China|39.9075,116.39723

Key Eligibility Criteria

  • Aged ≥65 years old
  • Pathologically confirmed non-small cell lung cancer with clinical stage eligible for curative surgical resection
  • Complete preoperative geriatric comprehensive assessment data available
  • Capable of finishing planned surgery and long-term follow-up

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →